Top US companies see devices for congestive heart failure as a booming product area
This article was originally published in Clinica
Devices to treat congestive heart failure are shaping up as the probable blockbuster product area for the year 2000. At last week's Piper Jaffray Investor Conference in Minneapolis, the top three US cardiovascular companies -Medtronic, Guidant and St Jude Medical-all discussed their work on pacemaker-type devices to treat this widespread and debilitating condition. Karen Riley reports.
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.